Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 17

1.

Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans.

Riccardi P, Li R, Ansari MS, Zald D, Park S, Dawant B, Anderson S, Doop M, Woodward N, Schoenberg E, Schmidt D, Baldwin R, Kessler R.

Neuropsychopharmacology. 2006 May;31(5):1016-26.

2.

The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.

Gründer G, Landvogt C, Vernaleken I, Buchholz HG, Ondracek J, Siessmeier T, Härtter S, Schreckenberger M, Stoeter P, Hiemke C, Rösch F, Wong DF, Bartenstein P.

Neuropsychopharmacology. 2006 May;31(5):1027-35.

3.

Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol.

Kessler RM, Ansari MS, Riccardi P, Li R, Jayathilake K, Dawant B, Meltzer HY.

Neuropsychopharmacology. 2005 Dec;30(12):2283-9.

4.
5.

Learning networks in health and Parkinson's disease: reproducibility and treatment effects.

Carbon M, Ghilardi MF, Feigin A, Fukuda M, Silvestri G, Mentis MJ, Ghez C, Moeller JR, Eidelberg D.

Hum Brain Mapp. 2003 Jul;19(3):197-211.

PMID:
12811735
6.
7.
8.

Basal ganglia and movement disorders: an update.

Chesselet MF, Delfs JM.

Trends Neurosci. 1996 Oct;19(10):417-22. Review.

PMID:
8888518
10.

Autoradiographic localization of [3H]sulpiride binding sites in the rat brain.

Gehlert DR, Wamsley JK.

Eur J Pharmacol. 1984 Feb 17;98(2):311-2. No abstract available.

PMID:
6714315
11.

Two dopamine receptors: biochemistry, physiology and pharmacology.

Stoof JC, Kebabian JW.

Life Sci. 1984 Dec 3;35(23):2281-96. Review.

PMID:
6390056
12.
13.

In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ([125I]-IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT.

Brücke T, Tsai YF, McLellan C, Singhanyom W, Kung HF, Cohen RM, Chiueh CC.

Life Sci. 1988;42(21):2097-104.

PMID:
3260318
14.

Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.

Seeman P, Bzowej NH, Guan HC, Bergeron C, Reynolds GP, Bird ED, Riederer P, Jellinger K, Tourtellotte WW.

Neuropsychopharmacology. 1987 Dec;1(1):5-15.

PMID:
2908095
15.

Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride.

Lidow MS, Goldman-Rakic PS, Rakic P, Innis RB.

Proc Natl Acad Sci U S A. 1989 Aug;86(16):6412-6.

16.

High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors.

Kessler RM, Ansari MS, Schmidt DE, de Paulis T, Clanton JA, Innis R, al-Tikriti M, Manning RG, Gillespie D.

Life Sci. 1991;49(8):617-28.

PMID:
1830917
17.

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.

Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G, George SR, Torchia J, Van Tol HH, Niznik HB.

Nature. 1991 Apr 18;350(6319):614-9.

PMID:
1826762

Supplemental Content

Support Center